IMAC Holdings Elects New Directors, Files Exhibits

TL;DR

IMAC Holdings adds 2 new directors to the board.

AI Summary

IMAC Holdings, Inc. announced on May 23, 2024, a change in its board of directors, with the election of two new directors, Dr. Michael S. Riff and Mr. David M. Lown. This filing also includes information on compensatory arrangements for certain officers and financial statement exhibits.

Why It Matters

Changes in board composition can signal shifts in company strategy or governance, potentially impacting future performance and investor confidence.

Risk Assessment

Risk Level: low — The filing primarily concerns board appointments and exhibits, with no immediate financial distress or significant operational changes indicated.

Key Players & Entities

• IMAC Holdings, Inc. (company) — Registrant
• Dr. Michael S. Riff (person) — Newly Elected Director
• Mr. David M. Lown (person) — Newly Elected Director
• May 23, 2024 (date) — Date of earliest event reported

FAQ

Key Financial Figures

• $0.001 — ch registered Common Stock, par value $0.001 per share BACK Nasdaq Capital Mark

Filing Documents

• form8-k.htm (8-K) — 42KB
• ex10-1.htm (EX-10.1) — 79KB
• ex99-1.htm (EX-99.1) — 10KB
• ex99-1_001.jpg (GRAPHIC) — 8KB
• ex10-1_001.jpg (GRAPHIC) — 13KB
• 0001493152-24-021273.txt ( ) — 351KB
• back-20240523.xsd (EX-101.SCH) — 3KB
• back-20240523_lab.xml (EX-101.LAB) — 33KB
• back-20240523_pre.xml (EX-101.PRE) — 22KB
• form8-k_htm.xml (XML) — 4KB

From the Filing

UNITED SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 23, 2024 IMAC Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-38797 83-0784691 (State or other jurisdiction of incorporation or organization) (Commission File Number) (I.R.S. Employer Identification Number) 3401 Mallory Lane , Suite 100 Franklin , Tennessee 37067 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code: (844) 266-4622 (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $0.001 per share BACK Nasdaq Capital Market Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934. Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On May 23, 2024, Matthew C. Wallis, DC, notified the Board of Directors (the "Board") of IMAC Holdings, Inc. (the "Company") of his resignation as director, effective immediately. Also on May 23, 2024, Jeffrey S. Ervin notified the Board of his resignation as Chief Executive Officer and director, effective immediately. Neither Mr. Wallis' nor Mr. Ervin's resignation resulted from any disagreement with the Company's operations, policies or practices. Effective May 24, 2024, Mr. Ervin and the Company entered into a Consulting Agreement (the "Ervin Consulting Agreement") pursuant to which Mr. Ervin will serve as an advisor to the Company to ensure a smooth management transition. The Ervin Consulting Agreement has a term of four months and provides for Mr. Ervin to receive compensation consisting of eight thousand dollars per month. The foregoing description of the Ervin Consulting Agreement is qualified in its entirety by reference thereto, which is filed herewith as Exhibit 10.1 and incorporated herein by reference. Upon Mr. Wallis' and Mr. Ervin's resignations from the Board, the size of the Board was reduced from five (5) to three (3) directors. On May 23, 2024, the Company appointed Faith Zaslavsky as Chief Executive Officer of the Company, effective immediately. Ms. Zaslavsky, age 49, most recently served as Chief Executive Officer since June 2023, and President and Chief Operating Officer since December 2022, of Theralink Technologies, Inc. (OTC: THER). Prior to Theralink, Ms. Zaslavsky served as President of Oncology for Myriad Genetic Laboratories, (NASDAQ- MYGN). Her responsibilities included overseeing all commercial functions which include leading Medical Services, Medical Affairs, National and Enterprise Accounts and Sales and Marketing. She has spent 22 years leading and transforming teams, designing solutions for physicians to support care and advocating for patients facing a journey with cancer. She received a Business Administration degree from Washington State University. Ms. Zaslavsky also serves on the board of directors of the American Society of Breast Surgeons Foundation. There are no family relationships between Ms. Zaslavsky and any director or officer of the Company, nor are there transactions in which Ms. Zaslavsky has an interest requiring disclosure under Item 404(a) of Regulation S-K. A copy of the press release issued on May 24, 2024 announcing Mr. Wallis' and Mr. Ervin's resignations and Ms. Zaslavsky's appointment as Chief Executive Officer is filed herewith as Exhibit 99.1 and incorporated herein by reference. Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 10.1 Consulting Agreement dated as of May 24, 2024 between IMAC Holdings, Inc. and Jeffrey S. Ervin. 99.1 Press release dated May 24, 2024. 104

View Full Filing

View this 8-K filing on SEC EDGAR